Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2022.09.009
PubMed Identifier: 36208569
Publication URI: http://europepmc.org/abstract/MED/36208569
Type: Journal Article/Review
Volume: 176
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049